课题基金 / 基金详情

Novel Innate Receptor for the Fungal PAMP chitin

Novel Innate Receptor for the Fungal PAMP chitin
真菌 PAMP 几丁质的新型先天受体
批准号:
8839039
负责人:
LIWU LI
金额:
$23.37万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-18 至 2017-04-30
关键词:
AcetylglucosamineAgeAlkaliesAllergensAllergicAllergic DiseaseAllergic rhinitisAlternariaAnimal ModelAspergillus fumigatusAsthmaAutomobile DrivingBindingBiochemicalBreathingCD4 Positive T LymphocytesCalorimetryCarbohydratesCell WallCell membraneCellsCessation of lifeChildChildhoodChitinChronicClinicalCollaborationsComplexCountryDataDendritic CellsDeveloped CountriesDevelopmentDiseaseEmployee StrikesEnvironmental Risk FactorEosinophiliaEpithelial CellsEquilibriumEventExhibitsExposure toExtrinsic asthmaFungal AntigensGenesGlucansGoalsHealthcare SystemsHumanHypersensitivityIRAK1 geneIgEImmuneImmune responseImmune systemImmunityIn VitroIndividualInflammationInflammatoryInflammatory ResponseInvestigationKineticsKnowledgeLeadLigandsLinkLungMucous body substanceMusNatural ImmunityNatureObstructionParasitesPathogenesisPathway interactionsPatientsPeptidoglycanPhasePhenotypePhosphotransferasesPlayPolymersPopulationPrevalencePreventionPrevention strategyProcessProductionProteinsPublic HealthRecombinantsRecurrenceReproduction sporesResearchRhinitisRoleSerumSignal TransductionSiteSmall Interfering RNASpecificityTestingTitrationsTranslatingUnited StatesUnited States National Institutes of HealthVariantWorkadaptive immunityairway hyperresponsivenessairway inflammationairway remodelingallergic airway diseaseallergic airway inflammationallergic responseclinical practicecytokinedectin 1designeffective therapyexperiencefallsfungusgalactomannanhuman IRAK1 proteinin vivoinsightmouse modelmutantnovelnovel therapeutic interventionpathogenpressurepublic health relevancereceptorresponsescreening

项目摘要

项目成果

LIWU LI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The inflammatory airway response in allergic asthma may be the result of immune cells that are dysregulated towards environmental factors such as airborne fungi. The long-term goal of this project is to better understand the pathophysiological mechanisms of Th2-type (allergic) airway inflammation. Exposure to the fungus, Alternaria, has long been implicated in the development and exacerbation of allergic airway disorders such as rhinitis, atopic asthma, and CRS. After intranasal exposure to Alternaria spores, antigens, and fungal cell wall polymers such as chitin, naive mice exhibit marked eosinophilic airway inflammation, enhanced Th2 responses, and airway hyperreactivity. Despite the well-documented clinical importance of Alternaria in the development, onset, and exacerbation of allergic airway diseases, little knowledge exists about the role of individual fungal products/components in theses pathological states. The importance of the fungal cell wall polymer chitin has been explored to some extent in the context of inflammation and has been shown to drive immune responses favoring the development of allergic disease. We have discovered a novel receptor candidate for chitin expressed in lung epithelial cells. In this exploratory project we will further our understanding of how chitin binds to this receptor and begin to elucidate the role of this receptor candidate in the context of innate immunity and allergic inflammatory responses using lung epithelial cells and mouse models. Execution of this project will lead to a better understanding of the mechanisms of persistent and recurrent airway inflammation and may lead to the development of more specific, effective therapies and prevention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of innate immune exhaustion during sepsis
Novel mechanisms for the generation of resolving monocytes
Altered innate leukocyte programming dynamics in sepsis
Altered innate leukocyte programming dynamics in sepsis
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: